alopecia areata

Medicolegal Implications of Regenerative Medicine and PRP
PRPNext Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Terrance Keaney, assistant clinical faculty of dermatology at GW School of Medicine and Health Sciences, and Howard University. Watch and find out why the FDA and Department of Justice are giving more attention to regenerative medicine in recent years. Learn how the FDA views platelet-ri …
PRP
A Case of Late-Onset Alopecia Areata
ALOPECIA AREATAINTRODUCTION Alopecia areata (AA) is a condition characterized by nonscarring hair loss. Cases of alopecia areata are most commonly seen in patients under age 30 and are frequently idiopathic. In this report, we discuss a woman in her 50s who developed AA shortly after receiving the Tdap vaccine and after one year of guselkumab therapy.   CASE A woman in her 50s with history of psor …
ALOPECIA AREATA
JDD September 2023 Issue Highlights | Special Focus: Aesthetic Treatments
aesthetic treatmentsWith a special focus on aesthetic treatments, check out highlights from the September issue of the Journal of Drugs in Dermatology (JDD) straight from the Editor’s desk: A Randomized Control Trial Comparing the Efficacy of Platelet-Rich Plasma and 5% Topical Minoxidil for the Treatment of Androgenetic Alopecia suggests that PRP therapy demonstrates a higher efficacy compared to minoxidil for t …
aesthetic treatments
Pediatric Hair Loss: Nuances in Clinical Presentation and Therapeutics
pediatric hair lossNext Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Candrice Heath, assistant professor of dermatology at the Lewis Katz School of Medicine at Temple University. Every dermatology clinician should know some very specific things about hair loss, according to Dr. Heath, including that children can present with adult hair conditions. Watch as Dr. Heath outlines three condit …
pediatric hair loss
JDD August 2023 Issue Highlights | Special Focus: Psoriasis
psoriasisWith a special focus on the topic of psoriasis, check out highlights from the August issue of the Journal of Drugs in Dermatology (JDD) straight from the JDD Editor’s desk: Consensus Statements on the Use of Corticosteroid-Containing Topical Medications in Psoriasis delves into the expert guidance provided by the Psoriasis Expert Group (PEG), encompassing nine crucial statements that offer com …
psoriasis